Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride
Abstract Background Metabolic reprogramming of energy processes is a cellular hallmark of various cancers. Whether trimetazidine, an anti-ischemic agent that preferentially potentiates cellular glucose oxidation, alters the long-term risk of malignancies is unknown. Methods In this multi-center, ret...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-025-00805-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|